Related Experiment Video
Updated: Jun 5, 2026

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation Post-Left Ventricular Assist Device
Gennaro Giustino1, Mostafa Naguib1, Chantal Y Asselin1
1Gagnon Cardiovascular Institute, Atlantic Health System, Morristown, New Jersey, USA.
Background:
The presence of severe tricuspid regurgitation (TR) in patients supported with durable left ventricular assist devices (LVADs) is associated with increased morbidity and mortality. The role of transcatheter interventions remains limited, but represents a promising therapeutic frontier.
Case Summary:
A 62-year-old woman with chemotherapy-induced cardiomyopathy underwent HeartMate 3 LVAD implantation, complicated by progressive right ventricular (RV) dilation, severe annular dilation, and torrential secondary TR with marked leaflet malcoaptation. Despite guideline-directed medical therapy and chronic inotropic support, she developed refractory RV failure with a ventricularized right atrial waveform on catheterization. Given prohibitive surgical risk, transfemoral transcatheter tricuspid valve replacement (TTVR) with a 56-mm Edwards EVOQUE valve was performed, resulting in near-complete TR elimination, improved RV-pulmonary artery coupling, and clinical recovery.
Discussion:
This case illustrates TTVR as a viable therapy for refractory TR and RV failure in select LVAD-supported patients.
Take-Home Message:
TTVR offers a definitive alternative for post-LVAD severe TR when surgical repair is not feasible.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Cardiomyopathy V: Interprofessional Care
Aortic Regurgitation III: Medical Management
